根据 COSMIN 指南，对镫骨成形术结局测试（SPOT-25）进行法语改编和验证。

French adaptation and validation of the Stapesplasty Outcome Test (SPOT-25), following COSMIN guidelines.

机构信息

Service d'Otorhinolaryngologie, Hôpital Fondation Adolphe de Rothschild, 29, rue Manin, 75019 Paris, France.

Médecin en Santé Publique, Unité de Recherche Clinique, Hôpital Fondation Adolphe de Rothschild, 29, rue Manin, 75019 Paris, France.

出版信息

Eur Ann Otorhinolaryngol Head Neck Dis. 2023 May;140(3):115-119. doi: 10.1016/j.anorl.2022.12.004. Epub 2023 Jan 9.

DOI:10.1016/j.anorl.2022.12.004

PMID:36631327

Abstract

AIMS

Otosclerosis can severely impact quality of life, but no questionnaire is available in French. The present study aimed to adapt and validate a French version of the SPOT-25.

MATERIALS AND METHODS

A controlled prospective study was conducted between September 2021 and April 2022. The translation used the "forward-backward" technique and statistical validation was performed in non-operated adult otosclerosis patients (cases) and a control group. Assessment Internal consistency, discrimination performance and test-retest reliability were assessed on global score, subscores and items.

RESULTS

Fifty-one cases and 58 control subjects filled out the test questionnaire and 35 of the 51 cases, also filled out the retest. Internal consistency on Cronbach alpha was 0.95 for the cases. Median total SPOT-25 score was 44 (range, 10-78) for cases and 2 (range, 0-33) for controls (p= P<0.0001). Test-retest reliability on intraclass correlation coefficient was excellent (ICC=0.92; [95% CI, 0.84-0.96]). Individual items all showed satisfactory performance.

CONCLUSION

The French version of SPOT-25 was short and easy to use, with satisfactory performance in assessing quality of life in otosclerosis patients.

摘要

目的

耳硬化症可严重影响生活质量，但目前尚无法语版问卷。本研究旨在对 SPOT-25 进行法语版的改编和验证。

材料与方法

一项在 2021 年 9 月至 2022 年 4 月之间进行的对照前瞻性研究。翻译采用“正向-反向”技术，并在未手术的成人耳硬化症患者（病例）和对照组中进行统计学验证。评估包括整体评分、子评分和项目的内部一致性、区分性能和测试-重测信度。

结果

51 例病例和 58 例对照组填写了测试问卷，其中 35 例病例还填写了重测问卷。病例的 Cronbach alpha 内部一致性为 0.95。病例的 SPOT-25 总分中位数为 44（范围，10-78），对照组为 2（范围，0-33）（p=P<0.0001）。病例的组内相关系数的重测信度为极好（ICC=0.92；[95%CI，0.84-0.96]）。各个项目均表现出良好的性能。